| Stephen M Levy, MD | |
|
10 James St, Suite 130, Florham Park, NJ 07932-1405 | |
| (973) 736-9557 | |
| (973) 736-9757 |
| Full Name | Stephen M Levy |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 36 Years |
| Location | 10 James St, Florham Park, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316947856 | NPI | - | NPPES |
| 6813402 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Medical Center | Morristown, NJ | Hospital |
| Saint Barnabas Medical Center | Livingston, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I code, 86481, is described as "Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension." This new code will be effective as of January 1, 2011.
Tim Muldoon, assistant professor of biomedical engineering, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue his work on an endoscopic probe that can be used in colonoscopies.
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease—a finding that could reverse long-standing clinical practice.
› Verified 9 days ago
| Entity Name | Cardiovascular Health Consultants, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437291739 PECOS PAC ID: 8325934706 Enrollment ID: O20040224000028 |
News Archive
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I code, 86481, is described as "Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension." This new code will be effective as of January 1, 2011.
Tim Muldoon, assistant professor of biomedical engineering, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue his work on an endoscopic probe that can be used in colonoscopies.
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease—a finding that could reverse long-standing clinical practice.
› Verified 9 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I code, 86481, is described as "Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension." This new code will be effective as of January 1, 2011.
Tim Muldoon, assistant professor of biomedical engineering, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue his work on an endoscopic probe that can be used in colonoscopies.
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease—a finding that could reverse long-standing clinical practice.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen M Levy, MD Po Box 416457, Boston, MA 02241-6457 Ph: () - | Stephen M Levy, MD 10 James St, Suite 130, Florham Park, NJ 07932-1405 Ph: (973) 736-9557 |
News Archive
Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.
Oxford Immunotec, Inc. announces that a new and specific Current Procedural Terminology (CPT®) code has been established by the American Medical Association for use with the T-SPOT®.TB test. The new Category I code, 86481, is described as "Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension." This new code will be effective as of January 1, 2011.
Tim Muldoon, assistant professor of biomedical engineering, has received a $500,000 Faculty Early Career Development Program award from the National Science Foundation to continue his work on an endoscopic probe that can be used in colonoscopies.
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney disease—a finding that could reverse long-standing clinical practice.
› Verified 9 days ago
Dr. Silvia Patricia Pinel-villalobos, D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 83 Hanover Rd, Suite 280, Florham Park, NJ 07932 Phone: 973-377-4100 Fax: 973-377-4101 | |
Noeen Ahmad, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Park Ave, Florham Park, NJ 07932 Phone: 973-404-9930 | |
Dr. Vanessa Nadia Trespalacios, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 83 Hanover Rd, Suite 280, Florham Park, NJ 07932 Phone: 973-377-4100 Fax: 973-377-4101 | |
Dr. Kezia Jasmina Ribeiro Alberto, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 83 Hanover Rd, Florham Park, NJ 07932 Phone: 973-736-2212 Fax: 973-736-2989 | |
Dr. Steven A Pally, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 James St, Suite 140, Florham Park, NJ 07932 Phone: 973-822-0770 Fax: 973-822-2062 | |
Dr. Alexander J Mathew, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 James St, Florham Park, NJ 07932 Phone: 973-295-6220 Fax: 973-295-6297 | |
Dr. Carlos Antonio Garay, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 48 Hillside Ave, Florham Park, NJ 07932 Phone: 973-295-6828 |